Crowdonomics
WatchlistPortfolio
All companies
Mercurius Biorefining, Inc logo

Mercurius Biorefining, Inc

Operating

Energy & Cleantech · Ferndale, WA

Visit website
Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$0
Across 1 round since 2018
Latest share price
$1.50
Reg CF Offering (2018) offering price

Financials

FY2016–FY2023 (no data for FY2020, FY2021) · from SEC filings · hover any figure for its source
$0
$9K
2016
$0
−$105K
2017
$28K
−$87K
2018
$82K
−$38K
2019
2020no data
2021no data
$259K
$73K
2022
$203K
−$9K
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2016 reviewed*
FY2017 reviewed*
FY2018
FY2019
FY2022
FY2023
Income statement
Revenue
$0
$0
$28,238
$82,209
$258,750
$202,500
Cost of goods sold
$0
$0
$0
$0
$0
$0
Gross margin
—
—
100%
100%
100%
100%
Net income
$9,227
-$104,611
-$87,300
-$37,682
$72,904
-$8,828
Taxes paid
$0
$0
$0
$0
$0
$0
Balance sheet
Cash
$33,033
$9,284
$1,530
$10,971
$2,991
$3,478
Accounts receivable
$0
$0
$0
$6,500
$0
$0
Total assets
$121,833
$80,484
$153,894
$200,111
$868,761
$937,790
Short-term debt
$287,618
$338,052
$512,506
$563,825
$1,118,272
$1,143,472
Long-term debt
$0
$0
$0
$0
$0
$0
Total liabilities
$287,618
$338,052
$512,506
$563,825
$1,118,272
$1,143,472
Other
Headcount
—
3
—
3
—
3

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Fundraising history

Reg CF · Common Stock · Nov 2018Closedvia Netcapital
Raised $0 / $1.1M

Team

2 people
Karl Seck
Principal Executive Officer
Michael Vevera
Principal Financial Officer

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not obligated

never closed a Reg CF raise

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARApr 30, 20240001669191-24-000511
    EDGAR
  • Form C-ARApr 29, 20200001669191-20-000213
    EDGAR
  • Form C/AFeb 20, 20190001669191-19-000062
    EDGAR
  • Form CNov 29, 20180001669191-18-000514
    EDGAR
Source: SEC EDGARCIK 0001760071WAShare price $1.50Last synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.